Dr. Shizuka Aritomi,
Research Center,
Ajinomoto Pharmaceuticals
Kanagawa,
Japan
Dr. Shizuka Aritomi is currently affiliated to Research Center, Ajinomoto Pharmaceuticals Kanagawa, Japan, continuing research in the specialized scientific area of calcium channels, cardioprotective and renoprotective effects of the L/N-type calcium channel blocker. Dr. Shizuka Aritomi has published his article in Journal of Hypertension: Open Access & other reputed journals and has authored several articles along with chapters in different books related to calcium channels, cardioprotective and renoprotective effects of the L/N-type calcium channel blocker
calcium channels, cardioprotective and renoprotective effects of the L/N-type calcium channel blocker
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report